Cardioprotective effects of carvedilol on acute autoimmune myocarditis.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2003-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1152/AJPHEART.00536.2003PMID 15124928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.

  2003cited by this paper
• Overexpression of Thioredoxin-1 in Transgenic Mice Attenuates Adriamycin-Induced Cardiotoxicity

  2002cited by this paper
• Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium

  2002cited by this paper
• Different Effects of Carvedilol, Metoprolol, and Propranolol on Left Ventricular Remodeling After Coronary Stenosis or After Permanent Coronary Occlusion in Rats

  2002cited by this paper
• Fc Receptor–Mediated Inhibitory Effect of Immunoglobulin Therapy on Autoimmune Giant Cell Myocarditis: Concomitant Suppression of the Expression of Dendritic Cells

  2001cited by this paper
• Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokines.

  2001cited by this paper
• Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF).

  2001cited by this paper
• Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy.

  2001cited by this paper
• Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

  2000cited by this paper
• Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids.

  2000cited by this paper
• Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

  2000cited by this paper
• Nadolol inhibits reactive oxygen species generation by leukocytes and linoleic acid oxidation.

  2000cited by this paper
• beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.

  2000cited by this paper
• From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future.

  1999cited by this paper
• Effect of beta-blockers on free radical-induced cardiac contractile dysfunction.

  1999cited by this paper
• Effect of (cid:98) -Blockers on Free Radical–Induced Cardiac Contractile Dysfunction

  1999cited by this paper
• The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

  1999cited by this paper
• Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure.

  1999cited by this paper
• Comparison of metoprolol and carvedilol pharmacology and cardioprotection in rabbit ischemia and reperfusion model.

  1998cited by this paper
• CARVEDILOL UPDATE IV : PREVENTION OF OXIDATIVE STRESS, CARDIAC REMODELING AND PROGRESSION OF CONGESTIVE HEART FAILURE

  1997cited by this paper
• Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart.

  1996cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators.

  1995cited by this paper
• Neurohumoral factors during transition from left ventricular hypertrophy to failure in Dahl salt-sensitive rats.

  1995cited by this paper
• Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect.

  1995cited by this paper
• Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage.

  1994cited by this paper
• Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy.

  1994cited by this paper
• Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.

  1992cited by this paper
• β‐Blocker Treatment of Dilated Cardiomyopathy: Beneficial Effect of Carteolol in Mice

  1991cited by this paper
• A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction.

  1990cited by this paper
• Effect of metoprolol in acute coxsackievirus B3 murine myocarditis.

  1988cited by this paper

• The Role of the Immune System in Pathobiology and Therapy of Myocarditis: A Review

  2024cites this paper
• Letter: Carvedilol vs Metoprolol: Mitigating Contrast-Induced Nephropathy in Acute Coronary Syndrome Patients

  2024cites this paper
• Effect of Carvedilol Versus Metoprolol on Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Intervention Therapy

  2023cites this paper
• Modern strategy for the treatment of myocarditis in children

  2022cites this paper
• Melissa officinalis L. Supplementation Provides Cardioprotection in a Rat Model of Experimental Autoimmune Myocarditis

  2022cites this paper
• Immunomodulatory properties of antihypertensive drugs and digitalis glycosides

  2022influential citation
• Managing Covid-19 in patients with heart failure: current status and future prospects

  2022cites this paper
• Repurposing Carvedilol as a Novel Inhibitor of the Trypanosoma cruzi Autophagy Flux That Affects Parasite Replication and Survival

  2021cites this paper
• 2020 Clinical practice guidelines for Myocarditis in adults

  2021cites this paper
• Facial flushing and erythema of rosacea improved by carvedilol

  2020cites this paper
• Nephroprotective Effect of Pleurotus ostreatus and Agaricus bisporus Extracts and Carvedilol on Ethylene Glycol-Induced Urolithiasis: Roles of NF-κB, p53, Bcl-2, Bax and Bak

  2020cites this paper
• Management and Treatment of Myocarditis in Athletes

  2020cites this paper
• Effect of carvedilol on arteriovenous graft primary patency

  2020cites this paper
• Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors

  2020cites this paper
• Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes

  2020cites this paper
• Myocarditis and Dilated Cardiomyopathy

  2020cites this paper
• Update on myocarditis - what we know so far and where we may be heading.

  2020cites this paper
• Myocarditis in Athletes Is a Challenge: Diagnosis, Risk Stratification, and Uncertainties.

  2020cites this paper
• Cardioprotective Mechanisms of Hypothyroidism on Ischemia/Reperfusion in Rats and Effects of Carvedilol: Energetic Study

  2020cites this paper
• Carvedilol prevents pancreatic β-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-κB, COX-2, iNOS and oxidative stress.

  2020cites this paper
• Myocarditis in the pediatric population: A review.

  2019cites this paper
• Arrhythmogenic Inflammatory Cardiomyopathy in Autoimmune Rheumatic Diseases: A Challenge for Cardio-Rheumatology

  2019cites this paper
• Therapies to limit myocardial injury in animal models of myocarditis: a systematic review and meta-analysis

  2019cites this paper
• Clinical Reviews: Clinical Arrhythmias

  2018cites this paper
• Myopericarditis with preserved left ventricular function secondary to Neisseria meningitidis.

  2018cites this paper
• Carvedilol Inhibits Matrix Metalloproteinase-2 Activation in Experimental Autoimmune Myocarditis: Possibilities of Cardioprotective Application

  2018cites this paper
• Arrhythmogenic Inflammatory Cardiomyopathy: A Review.

  2018cites this paper
• Protective Effect of Carvedilol on Paracetamol-induced Hepatotoxicity; Role of Modulation Inflammation and Lipid Peroxidation

  2017cites this paper
• Carvedilol exacerbate gentamicin-induced kidney mitochondrial alterations in adult rat.

  2017cites this paper
• Established and novel treatment options in acute myocarditis, with or without heart failure

  2017cites this paper
• Counteraction of adriamycin-induced alterations in cardiac enzymes by Thespesia populnea leaf extract

  2017cites this paper
• Myocarditis.

  2016cites this paper
• Effect of aliskiren and carvedilol on expression of Ca2+/calmodulin-dependent protein kinase II δ-subunit isoforms in cardiac hypertrophy rat model

  2016cites this paper
• Autonomic Nervous System in Viral Myocarditis: Pathophysiology and Therapy.

  2016cites this paper
• Carvedilol suppresses cartilage matrix destruction.

  2016cites this paper
• virus diseases Myocarditis

  2016cites this paper
• Correlations of the changes in bioptic findings with echocardiographic, clinical and laboratory parameters in patients with inflammatory cardiomyopathy

  2016cites this paper
• The role of anti-myosin antibodies in perpetuating cardiac damage following myocardial infarction.

  2016cites this paper
• Drugs Targeting the Canonical NF-κB Pathway to Treat Viral and Autoimmune Myocarditis.

  2016cites this paper
• Recent advances in the management of autoimmune myocarditis: insights from animal studies.

  2016cites this paper
• Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-κB activation and oxidative stress mediators.

  2016cites this paper
• Interplay between stress granules, cellular stress response, and coxsackievirus B3 infection

  2016cites this paper
• immunodeficient mice transferred autoimmune myocarditis in severe combined Immunoglobulin treatment suppressed adoptively

  2016cites this paper
• Diagnosis and treatment strategies for children with myocarditis

  2016cites this paper
• What are the benefits of two-dimensional speckle tracking echocardiography for diagnosis and treatment follow-up of childhood-onset systemic lupus erythematosus myocarditis?

  2016cites this paper
• Anti‐inflammatory role of obestatin in autoimmune myocarditis

  2016cites this paper
• Protective mechanisms of berberine against experimental autoimmune myocarditis in a rat model.

  2016cites this paper
• Challenges and Opportunities in Pediatric Heart Failure and Transplantation

  2015cites this paper
• Targeting Inflammation: Impact on Atherothrombosis

  2014cites this paper
• Acute Mechanical Circulatory Support for Fulminant Myocarditis Complicated by Cardiogenic Shock

  2014cites this paper
• Diagnosis and treatment of myocarditis in children in the current era.

  2014cites this paper
• Experimental drugs for treatment of autoimmune myocarditis.

  2014cites this paper
• β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression.

  2014cites this paper
• EVIEW anagement of pericarditis and yocarditis : Could heart-rate-reducing rugs hold a promise ? rise en charge des péricardites et myocardites : les médicaments radycardisants sont-ils prometteurs ?

  2013cites this paper
• The Clinical and Diagnostic Significance of Anti-myosin Autoantibodies in Cardiac Disease

  2013cites this paper
• Earlier detection can help avoid many serious complications of peripartum cardiomyopathy.

  2013cites this paper
• Management of pericarditis and myocarditis: could heart-rate-reducing drugs hold a promise?

  2013cites this paper
• Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide production.

  2013influential citation
• Carvedilol Decrease IL-1β and TNF-α, Inhibits MMP-2, MMP-9, COX-2, and RANKL Expression, and Up-Regulates OPG in a Rat Model of Periodontitis

  2013cites this paper
• マウスの実験的動脈硬化に対する3種類のβアドレナリン受容体遮断薬 (プロプラノロール, メトプロロール, カルベジロール) の効果

  2013cites this paper
• The mechanism of carvedilol in experimental viral myocarditis.

  2012cites this paper
• Update on myocarditis.

  2012cites this paper
• CARDIOMYOPATHY-TACHYCARDIA INDUCED? REVIEW

  2012cites this paper
• Carvedilol blocks the cloned cardiac Kv1.5 channels in a β-adrenergic receptor-independent manner.

  2012cites this paper
• Suppression of Myocardial Injury Markers following Percutaneous Coronary Interventions by Pre-treatment with Carvedilol

  2012cites this paper
• Carvedilol reduces the severity of atherosclerosis in apolipoprotein E-deficient mice via reducing superoxide production

  2012cites this paper
• Cardioprotective effect of NO‐metoprolol in murine coxsackievirus B3‐induced myocarditis

  2010cites this paper
• What’s next in peripartum cardiomyopathy investigation?

  2010cites this paper
• Inflammatory markers and cytokines in peripartum cardiomyopathy: a delicate balance

  2010cites this paper
• The antioxidant edaravone attenuates ER-stress-mediated cardiac apoptosis and dysfunction in rats with autoimmune myocarditis

  2010cites this paper
• Autoimmune Murine Myocarditis and Immunomodulatory Interventions

  2010cites this paper
• Effects of angiotensin-II receptor blockers on experimental autoimmune myocarditis.

  2009cites this paper
• Inhibition of Ethanol-Induced Gastric Mucosal Damage by Carvedilol in Male Wistar Albino Rats: Possible Biochemical Changes

  2009cites this paper
• Pharmacological effects of carvedilol on T-type calcium current in murine HL-1 cells.

  2009cites this paper
• Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats

  2009cites this paper
• Neuroprotective effect of carvedilol, an adrenergic antagonist against colchicine induced cognitive impairment and oxidative damage in rat.

  2009cites this paper
• Protective Effects of Carvedilol in Murine Model With the Coxsackievirus B3-Induced Viral Myocarditis

  2008cites this paper
• Magnetic resonance imaging in a patient with peripartum cardiomyopathy.

  2008cites this paper
• Antioxidant activity of carvedilol in cardiovascular disease

  2007cites this paper
• Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol.

  2007cites this paper
• Effects of carvedilol on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.

  2007cites this paper
• Effect of beta-adrenergic and renin-angiotensin system blockade on myocyte apoptosis and oxidative stress in diabetic hypertensive rats.

  2007cites this paper
• Autonomic imbalance and immune activation in chronic heart failure - pathophysiological links.

  2006cites this paper
• Perturbing effects of carvedilol on a model membrane system: role of lipophilicity and chemical structure.

  2006cites this paper
• β2-Adrenergic Agonists Suppress Rat Autoimmune Myocarditis: Potential Role of β2-Adrenergic Stimulants as New Therapeutic Agents for Myocarditis

  2006cites this paper
• Biomarkers of oxidative damage in human disease.

  2006cites this paper
• Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.

  2005cites this paper
• Nutrition and metabolism Intentional weight loss, blood lipids and coronary morbidity and mortality Review: Intentional weight loss, blood lipids and coronary morbidity and mortality (pp. 5–9)

  2005cites this paper
• Myocarditis: the immunologist's view on pathogenesis and treatment.

  2005cites this paper
• Cardioprotective effects of peroxisome proliferator activated receptor γ activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor κB blockade

  2005cites this paper
• Tachycardia‐Induced Cardiomyopathy: A Review of Literature

  2005cites this paper
• Coxsackievirus-induced myocarditis: new trends in treatment

  2005cites this paper
• Pharmacokinetics and Pharmacodynamics of Beta Blockers in Heart Failure

  2004cites this paper
• Immunoglobulin treatment suppressed adoptively transferred autoimmune myocarditis in severe combined immunodeficient mice.

  2004cites this paper
• Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy.

  2004cites this paper
• Effects of chromanol 293B on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.

  2003cites this paper
• ' s response to reviews Title : Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B 3-induced myocarditis

  year unknowncites this paper
• Cardiovascular Case Series 1703 Foreword

  year unknowncites this paper